Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman’s disease
Angenendt L., Kerkhoff A., Wiebe S., Mikesch J., Rudat A., Wötzel F., Wenning C., Schliemann C., Kessler T., Schäfers M., Wardelmann E., Stelljes M., Berdel W.
Research article (journal) | Peer reviewedDetails about the publication
Journal: Annals of Hematology (Ann Hematol)
Volume: 94
Issue: 7
Page range: 1241-1243
Status: Published
Release year: 2015
Language in which the publication is written: English
Link to the full text: http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84937512038&origin=inward
Authors from the University of Münster
| Angenendt, Linus | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
| Keßler, Torsten | FB05 - Faculty of Medicine (FB05) |
| Mikesch, Jan-Henrik | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
| Schliemann, Christoph | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
| Wardelmann, Eva Erika | Gerhard Domagk Institute of Pathology |